Exploratory analysis of the economically justifiable price of reslizumab for asthma severe in Colombia
Abstract Introduction Asthma severe imposes important economic burden for health systems, especially with the incorporation of new drugs. Recently, reslizumab has been approved to prevent exacerbations in patients with eosinophilic asthma. This study evaluates the price at which reslizumab would be...
-д хадгалсан:
| Үндсэн зохиолчид: | , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2025-06-01
|
| Цуврал: | BMC Public Health |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1186/s12889-025-23205-1 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|